The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lee Tom Y since 2016.
This trader's CIK number is 1623609.
At the time of last reporting, Lee Tom Y was the Chief Executive Officer of Pure Bioscience, Inc.. (stock ticker symbol PURE).
Also see all insider trading activities at Pure Bioscience, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | PURE | 269,477 | $49,371 | 0 | $0 | 0 | $0 |
| 2021 | PURE | 35,998 | $15,515 | 0 | $0 | 0 | $0 |
| 2020 | PURE | 1,088,762 | $715,849 | 0 | $0 | 0 | $0 |
| 2019 | PURE | 1,000,000 | $290,000 | 0 | $0 | 0 | $0 |
| 2018 | PURE | 2,336,187 | $1,051,284 | 0 | $0 | 0 | $0 |
| 2017 | PURE | 18,666,666 | $0 | 0 | $0 | 486,666 | $243,333 |
| 2016 | PURE | 0 | $0 | 14,885 | $14,140 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-12-15 | PURE | Buy | 50,000 | .13 | 6,550 |
| 2022-03-16 | PURE | Buy | 21,227 | .18 | 3,820 |
| 2022-03-17 | PURE | Buy | 13,250 | .18 | 2,371 |
| 2022-03-21 | PURE | Buy | 185,000 | .20 | 36,630 |
| 2021-06-16 | PURE | Buy | 35,998 | .43 | 15,515 |
| 2020-12-17 | PURE | Buy | 4,712 | .65 | 3,062 |
| 2020-12-16 | PURE | Buy | 20,000 | .67 | 13,300 |
| 2020-12-24 | PURE | Buy | 851 | .65 | 553 |
| 2020-12-22 | PURE | Buy | 45,299 | .66 | 29,987 |
| 2020-12-21 | PURE | Buy | 7,859 | .68 | 5,344 |
| 2020-06-18 | PURE | Buy | 30,000 | 1.75 | 52,500 |
| 2020-06-19 | PURE | Buy | 10,000 | 1.85 | 18,500 |
| 2020-06-22 | PURE | Buy | 13,124 | 1.72 | 22,573 |
| 2020-06-12 | PURE | Buy | 45,157 | 1.91 | 86,204 |
| 2020-06-15 | PURE | Buy | 60,000 | 1.82 | 109,200 |
| 2020-06-16 | PURE | Buy | 70,000 | 1.62 | 113,330 |
| 2020-06-17 | PURE | Buy | 26,876 | 1.60 | 43,135 |
| 2019-12-19 | PURE | Buy | 754,884 | .29 | 218,161 |
| 2019-10-02 | PURE | Buy | 1,000,000 | .29 | 290,000 |
| 2018-08-16 | PURE | Buy | 2,336,187 | .45 | 1,051,284 |
| 2017-12-29 | PURE | Buy | 18,666,666 | .00 | 0 |
| 2017-09-25 | PURE | Option Ex | 486,666 | .50 | 243,333 |
| 2016-12-21 | PURE | Sale | 14,885 | .95 | 14,140 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lee Tom Y (Chief Executive Officer of Pure Bioscience, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.